Skip to main content

Table 3 Differences between patients and physicians perceptions

From: Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

Ā 

Physicians (Nā€‰=ā€‰12) mean (SE)

Patients (Nā€‰=ā€‰25) mean (SE)

p value

Transplant-related mortality risk perception

4,9

3.6

0,001*

(1 to 7 Likert Scale)

(0,3)

(0.2)

Percent value of mortality risk communicated and recalled

30.0

20.4

0,005*

(% value from 5% to 50%)

(2.6)

(1.4)

Percent value of mortality risk considered acceptable to undergo the transplant procedure

19.6

29.6

0,005*

(% value from 5% to 50%)

(2.5)

(2.2)

Perception of GVHD as a severe life-threatening condition

5.4

4.1

0,006*

(1 to 7 Likert Scale)

(0.4)

(0.2)

How much previous information had influenced the patient before informed consent

4.6

2.2

0,006*

(1 to 7 Likert Scale)

(0.4)

(0.3)

Motivation to undergo HSCT before informed consent

4.6

4.8

NS

(1 to 7 Likert Scale)

(0.5)

(0.3)

  1. *Two-tailed t test significant value; GVHD: Graft Versus Host Disease; SE: standard error.